Teva reorganization 'complete', copaxone not ‘elephant’
This article was originally published in Scrip
Executive Summary
The Teva Pharmaceutical Industries train "has left the station", according to CEO Jeremy Levin. Speaking at the Goldman Sachs Healthcare Conference on 13 June, he said Teva's new management team was fully in place, all the major steps in reorganizing the company had been completed, and having stabilized the company, "we've started to look very aggressively to the future".